Abstract

LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure. (Funded by Novartis; PARADIGM-HF ClinicalTrials.gov number, NCT01035255.).

Keywords

EnalaprilNeprilysinHeart failureInternal medicineCardiologyRenin–angiotensin systemMedicineAngiotensin-converting enzymeChemistryBlood pressureEnzymeBiochemistry

Affiliated Institutions

Related Publications

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin‐converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM‐HF)

John J.V. McMurray , Milton Packer , Akshay S. Desai +8 more

Aims Although the focus of therapeutic intervention has been on neurohormonal pathways thought to be harmful in heart failure (HF), such as the renin–angiotensin–aldosterone sys...

2013 European Journal of Heart Failure 439 citations

Baseline characteristics and treatment of patients in Prospective comparison of <scp>ARNI</scp> with <scp>ACEI</scp> to Determine Impact on Global Mortality and morbidity in Heart Failure trial (<scp>PARADIGM‐HF</scp>)

John J.V. McMurray , Milton Packer , Akshay S. Desai +8 more

Aim To describe the baseline characteristics and treatment of the patients randomized in the PARADIGM‐HF (Prospective comparison of ARNi with ACEi to Determine Impact on Global ...

2014 European Journal of Heart Failure 167 citations

Publication Info

Year
2014
Type
article
Volume
371
Issue
11
Pages
993-1004
Citations
6494
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

6494
OpenAlex

Cite This

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. (2014). Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine , 371 (11) , 993-1004. https://doi.org/10.1056/nejmoa1409077

Identifiers

DOI
10.1056/nejmoa1409077